Mersana Therapeutics Inc
Biotechnology
Healthcare
MRSN
4.98 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.38
52 week high
8.11
high
7.54
52 week low
0.00
low
7.23
growth
239.81 %
previous Close
7.35
P/E ratio
market cap
35.10 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
875.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top